Q4 2024 Coloplast A/S Earnings Call TranscriptNov 05, 2024$130Earnings- Q3 2024 Coloplast A/S Earnings Call TranscriptAug 20, 2024$128.6 (-3.71%)Earnings
- Q2 2024 Coloplast A/S Earnings Call TranscriptMay 07, 2024$120.88 (+0.53%)Earnings
- Q1 2024 Coloplast A/S Earnings Call TranscriptFeb 09, 2024$129.17 (+13.96%)Earnings
- Q4 2023 Coloplast A/S Earnings Call TranscriptNov 09, 2023$105.92Earnings
- Coloplast A/S to Discuss Complete Acquisition of Kerecis Call TranscriptSep 04, 2023
- Q3 2023 Coloplast A/S Earnings Call TranscriptAug 17, 2023$115.07 (-4.11%)Earnings
- Coloplast A/S Announces Agreement to Acquire Kerecis Call TranscriptJul 07, 2023
- Q2 2023 Coloplast A/S Earnings Call TranscriptMay 11, 2023$143.5Earnings
- Q1 2023 Coloplast A/S Earnings Call TranscriptFeb 03, 2023$121.77 (-1.24%)Earnings
- Coloplast A/S Annual Shareholders Meeting TranscriptDec 01, 2022
- Q4 2022 Coloplast A/S Earnings Call TranscriptNov 07, 2022$107.38Earnings
- Coloplast A/S Meet the Management Event TranscriptAug 31, 2022
- Q3 2022 Coloplast A/S Earnings Call TranscriptAug 17, 2022$124.21 (+11.65%)Earnings
- Q2 2022 Coloplast A/S Earnings Call TranscriptMay 05, 2022$139.23 (-0.91%)Earnings
- Coloplast A/S Virtual ESG Event Call TranscriptMar 22, 2022
- Q1 2022 Coloplast A/S Earnings Call TranscriptJan 25, 2022$143.47Earnings
- Coloplast A/S Annual Shareholders Meeting TranscriptDec 02, 2021
- Coloplast A/S to Acquire Atos Medical Call TranscriptNov 08, 2021
- Q4 2021 Coloplast A/S Earnings Call TranscriptNov 01, 2021$160.73 (-3.88%)Earnings
- Q3 2021 Coloplast A/S Earnings Call TranscriptAug 18, 2021$185.25Earnings
- Q2 2021 Coloplast A/S Earnings Call TranscriptMay 06, 2021$163.62 (-2.72%)Earnings
- Q1 2021 Coloplast A/S Earnings Call TranscriptFeb 02, 2021$166.09 (+5.51%)Earnings
- Coloplast A/S at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Q4 2020 Coloplast A/S Earnings Call TranscriptNov 03, 2020$145.51 (+0.22%)Earnings
- Coloplast A/S Virtual Sustainability Deep-Dive Session TranscriptOct 09, 2020
- Coloplast A/S Virtual Deep-Dive Sessions TranscriptOct 07, 2020
- Coloplast A/S Virtual Capital Markets Day TranscriptSep 29, 2020
- Q3 2020 Coloplast A/S Earnings Call TranscriptAug 18, 2020$161.91 (-2.76%)Earnings
- Coloplast A/S at UBS Global Healthcare Conference (Virtual) TranscriptMay 20, 2020
- Q2 2020 Coloplast A/S Earnings Call TranscriptMay 06, 2020$151.96 (-3.06%)Earnings
- Coloplast A/S Revised Full Year Organic Growth and EBIT Margin Guidance for 2019/2020 Call TranscriptMar 19, 2020
- Q1 2020 Coloplast A/S Earnings Call TranscriptFeb 06, 2020$130Earnings
- Coloplast A/S Annual Shareholders Meeting TranscriptDec 05, 2019
- Q4 2019 Coloplast A/S Earnings Call TranscriptNov 05, 2019$119.95Earnings
- Coloplast A/S Meet the Management Event TranscriptAug 20, 2019
- Q3 2019 Coloplast A/S Earnings Call TranscriptAug 14, 2019$117.55Earnings
- Q2 2019 Coloplast A/S Earnings Call TranscriptMay 02, 2019$106.25Earnings
Q4 2024 Coloplast A/S Earnings Call Transcript
/- -
Thank you very much, operator. Good morning, and welcome to our full year '23, '24 conference call. I am Kristian Villumsen, the CEO of Coloplast, and I'm joined by our CFO, Anders Lonning-Skovgaard, and our Investor Relations team. We'll start with a short presentation by Anders and myself and then open up for questions as we usually do.
Please turn to slide number 3. We delivered 8% organic growth and a reported EBIT margin before special items of 27% for the '23, '24 financial year. Return on invested capital after tax and before special items was 15%, reflecting impact from the acquisition of Kerecis. This year, we continue to help millions of people within healthcare needs, and we also welcome more than 270,000 new users to our support program, Coloplast care.
In our fourth quarter, we delivered organic growth of 8% and a reported EBIT margin before special items of 26%. Anders will take you through the details later, but the EBIT
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
